NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 150

Registration Number: NCT00000939

Locations: 🇺🇸
Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium, San Jose, California, United States
🇺🇸
San Mateo AIDS Program / Stanford Univ, Stanford, California, United States
🇺🇸
Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States

and more 16 locations

A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies

Phase 3

Completed

Conditions: Pregnancy
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 1244

Registration Number: NCT00000942

Locations: 🇮🇹
Universita Frederico II, Napoli, Italy
🇧🇸
Princess Margaret Hosp, Nassau, Bahamas
🇫🇷
CHRU de Nantes, Nantes, France

and more 2 locations

A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-28

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 20

Registration Number: NCT00000833

Locations: 🇺🇸
Schneider Children's Hosp, New Hyde Park, New York, United States
🇺🇸
Children's Hosp of Boston, Boston, Massachusetts, United States
🇺🇸
Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark, New Jersey, United States

and more 12 locations

An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 6

Registration Number: NCT00000647

Locations: 🇺🇸
Natl Inst of Allergy & Infect Dis / Cln Ctr, Bethesda, Maryland, United States

A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy

Phase 1

Completed

Conditions: Cytomegalovirus Retinitis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 38

Registration Number: NCT00000673

Locations: 🇺🇸
Univ. of Miami AIDS CRS, Miami, Florida, United States
🇺🇸
Washington U CRS, Saint Louis, Missouri, United States

A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 471

Registration Number: NCT00000803

Locations: 🇺🇸
Bmc Actg Crs, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital ACTG CRS, Boston, Massachusetts, United States
🇺🇸
University of Washington AIDS CRS, Seattle, Washington, United States

and more 29 locations

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 105

Registration Number: NCT00001057

Locations: 🇺🇸
Univ of Nebraska Med Ctr, Omaha, Nebraska, United States
🇺🇸
Case Western Reserve Univ, Cleveland, Ohio, United States
🇺🇸
Thomas Jefferson Univ Hosp, Philadelphia, Pennsylvania, United States

and more 4 locations

Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma

Phase 2

Completed

Conditions: Sarcoma, Kaposi
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00000687

Locations: 🇺🇸
Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States
🇺🇸
Univ. of Miami AIDS CRS, Miami, Florida, United States
🇺🇸
Pitt CRS, Pittsburgh, Pennsylvania, United States

and more 6 locations

A Study of Zidovudine in HIV-Infected Patients With Kidney Problems

Phase 1

Withdrawn

Conditions: HIV Infections
Kidney Disease

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00000685

Locations: 🇺🇸
Univ of Washington, Seattle, Washington, United States
🇺🇸
Univ of North Carolina, Chapel Hill, North Carolina, United States

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 72

Registration Number: NCT00000825

Locations: 🇺🇸
Thomas Street Clinic C605-020 CRS, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy